Clinical trial
Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination…
NCT00140361 · Centers for Disease Control and Prevention, U.S. Fed · Completed
Key facts
| NCT number | NCT00140361 |
|---|---|
| Title | Efficacy of Sulphadoxine-pyrimethamine and Artemisinin-containing Combination Therapy for Malaria |
| Official title | Assessing and Monitoring the Efficacy of Sulfadoxine/ Pyrimethamine (SP) and the Combination of SP Plus Artesunate for Uncomplicated Malaria Infections Among Children |
| Lead sponsor | Centers for Disease Control and Prevention, U.S. Fed |
| Collaborators | United States Agency for International Development (USAID) U.S. Fed |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Malaria (Uncomplicated) |
| Intervention type | Behavioral, Drug |
| Interventions | Sulfadoxine-pyrimethamine, sulfadoxine-pyrimethamine plus artesunate, lumefantrine plus artemether, Sleeping under insecticide-treated bednet |
| Enrollment | 390 |
| Start date | Jan 1, 2000 |
| Primary completion | Jan 1, 2008 |
| Completion | Jan 1, 2008 |
| First posted | Sep 1, 2005 |
| Last update posted | Sep 11, 2012 |
| Countries | Tanzania |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: